Healthcare
0
Opioid prescriptions after surgery decline – Healthcare Economist
0

That is the discovery of a Open JAMA Network paper for Zhang et al. (2023). The authors use 2016-2022 data from the ...

0
North Carolina AG Sues HCA Healthcare over Mission Health Issues
0

North Carolina Attorney General Josh Stein announced on December 14 that it is suing the Nashville-based 182-hospital hospital HCA Health system for ...

0
Strong year for drug discovery – Healthcare Economist
0

2023 was a good year for drug discovery. Mullard et al. (2024) report: The FDA's Center for Drug Evaluation and ...

0
Intermountain Healthcare Opens Ambulatory Surgery Center In Murray, Utah
0

Health care between mountains (Salt Lake City) opened an outpatient surgery center and recovery hotel in Murray, Utah. The 50,000-square-foot project, which ...

0
OSF HealthCare To Expand St. Joseph Medical Center In Bloomington, Illinois
0

Catholic non-profit health organization. OSF Health Care (Peoria, Illinois) is planning a $17.8 million expansion project in San Jose Medical Center in ...

0
How are drugs developed and financed? An overview – Healthcare Economist
0

I just found a good general article titled The financial ecosystem of pharmaceutical R&D. The white paper was developed for the government of the ...

0
Four Design Strategies To Extend The Lifespan Of Healthcare Facilities
0

Linaea Floden photo credit: Ryan Companies As healthcare procedures and processes evolve, hospitals and patient care facilities increasingly find value in ...

0
US health care spending in 2022 – Healthcare Economist
0

It appears that healthcare spending as a percentage of GDP has stabilized. While it reached close to 20% of GDP during ...

0
The Carer QALY Trap – Healthcare Economist
0

The term “caregiver QALY” was coined in an article by Mott et al. (2023) and is identified as the case where "It is possible that an effective treatment ...

0
Do first-in-class cancer drugs receive a pricing premium? – Healthcare Economist
0

According to an article by Miljković et al. (2023)the answer is 'No'. The authors examine cancer treatments with FDA ...

Tools4BLS
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart